Horiguchi J, Takei H, Koibuchi Y, Iijima K, Ikeda F, Ochiai R, Uchida K, Yoshida M, Yokoe T, Morishita Y
Second Department of Surgery, Gunma University Faculty of Medicine, Maebashi, Japan.
Anticancer Res. 2001 Jul-Aug;21(4B):2963-7.
The purpose of this study was to compare the results of 133 cases (131 patients) of subcutaneous mastectomy with axillary dissection between 1983 and 1999 and 910 cases of radical mastectomy during the same period. The median follow-up period of the subcutaneous mastectomy group and the radical mastectomy group were 66 months and 81 months, respectively. The age at operation was significantly (p<0.01) younger in the subcutaneous mastectomy group than in the radical mastectomy group and the clinical stage was significantly (p<0.01) earlier. Lymph node metastasis was significantly (p<0.01) higher in the radical mastectomy than in the subcutaneous mastectomy group. There was no difference in ER status between the two groups. There was local recurrence in 5 (3.8%) members of the subcutaneous mastectomy group and in 12 (1.3%) members of the radical mastectomy group. There was no difference in disease-free survival and overall survival between the two groups. Divided into two subgroups by lymph node status, there was no difference in disease-free survival and overall survival between the two groups. Local recurrence occurred more frequently (p<0.05) in the subcutaneous mastectomy group, however, than in the radical mastectomy group when no lymph node metastasis was found. Multivariate analysis using the Cox hazard model showed that operation method and lymph node status were independent prognostic factors for local recurrence, whereas, lymph node status and ER status were independent prognostic factors of disease-free survival. In conclusion, subcutaneous mastectomy presents a risk factor for local recurrence, but the survival rate of the subcutaneous mastectomy group is as favourable as the radical mastectomy group.
本研究旨在比较1983年至1999年间133例(131名患者)皮下乳房切除术加腋窝清扫术与同期910例根治性乳房切除术的结果。皮下乳房切除术组和根治性乳房切除术组的中位随访期分别为66个月和81个月。皮下乳房切除术组的手术年龄显著(p<0.01)低于根治性乳房切除术组,临床分期也显著(p<0.01)更早。根治性乳房切除术中淋巴结转移率显著(p<0.01)高于皮下乳房切除术组。两组之间雌激素受体(ER)状态无差异。皮下乳房切除术组有5名(3.8%)患者出现局部复发,根治性乳房切除术组有12名(1.3%)患者出现局部复发。两组之间无病生存率和总生存率无差异。按淋巴结状态分为两个亚组,两组之间无病生存率和总生存率无差异。然而,在未发现淋巴结转移的情况下,皮下乳房切除术组的局部复发发生率高于根治性乳房切除术组(p<0.05)。使用Cox风险模型进行多因素分析显示,手术方式和淋巴结状态是局部复发的独立预后因素,而淋巴结状态和ER状态是无病生存的独立预后因素。总之,皮下乳房切除术是局部复发的一个危险因素,但皮下乳房切除术组的生存率与根治性乳房切除术组一样良好。